Emerging genetic studies implicate microglia in Alzheimer’s disease and other brain diseases, yet it's unclear how they contribute to cognitive dysfunction. Microglia eliminates synaptic connections using molecules from the innate immune system, shedding light on mechanisms of pathological synapse loss. This session will outline paths to define microglia-mediated disease mechanisms, highlighting new models and approaches that bridge gaps between genetics, cellular states, and function.
This was selected as a part of the Neuroscience 2024 programming: Theme A – Development.
This session will be moderated by Michelle Gray, PhD, 2024 Program Committee Member.
Registration is open for all upcoming webinars. The webinars are complimentary for SfN members and $15 for nonmembers. Activate your account to receive member access to webinars.
